RECRUITING

Personalizing Treatment Delivery

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Anxiety and anxiety-related disorders frequently co-occur with alcohol use problems resulting in an enormous humanitarian and economic cost to society. The proposed research will use digital technology to examine person-specific risk factors predicting problematic alcohol use in individuals vulnerable to anxiety and anxiety-related disorders and will use this information to design a personalized intervention for individuals seeking psychological treatment. Results from this research will integrate output from novel and innovative digital technology methods into psychotherapy, advancing research on personalized treatment and prevention efforts.

Official Title

Digital Phenotyping of Anxiety and Anxiety-Related Alcohol Comorbidity and Treatment

Quick Facts

Study Start:2024-09-30
Study Completion:2027-04
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05821634

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Access to a smart phone
  2. * Between 18 and 65 years
  3. * Clinically significant anxiety or trauma-related symptoms
  4. * Alcohol use problems
  5. * Interest in telehealth counseling
  6. * Anticipated New Jersey or New York residence for the duration of the study
  1. * Currently receiving counseling
  2. * Psychiatric medication that is not currently at a stable dose (or is not anticipated to remain at a stable dose for the duration of the study)
  3. * Demonstrated indicators of more intensive or acute care
  4. * Temporary residence within the state of New Jersey or New York or out-of-state residence from the state of New Jersey or New York

Contacts and Locations

Study Contact

Marilyn Piccirillo, PhD
CONTACT
732-235-4341
marilyn.piccirillo@rutgers.edu

Principal Investigator

Marilyn Piccirillo, PhD
PRINCIPAL_INVESTIGATOR
Rutgers Robert Wood Johnson Medical School

Study Locations (Sites)

Rutgers Robert Wood Johnson Medical School
Piscataway, New Jersey, 08901
United States

Collaborators and Investigators

Sponsor: Rutgers, The State University of New Jersey

  • Marilyn Piccirillo, PhD, PRINCIPAL_INVESTIGATOR, Rutgers Robert Wood Johnson Medical School

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-30
Study Completion Date2027-04

Study Record Updates

Study Start Date2024-09-30
Study Completion Date2027-04

Terms related to this study

Additional Relevant MeSH Terms

  • Anxiety Disorders and Symptoms
  • PTSD and Trauma-related Symptoms
  • Alcohol; Use, Problem; Alcohol Use Disorder